Nationwide nested case-control data showed current oral hormone therapy increased VTE (HR 1.6), ischemic stroke (HR 1.3), and ...
Despite technology fostering a new generation of health care delivery, experts believe rural health solutions should be ...
Medicaid coverage of obesity-labeled GLP-1 receptor agonists may substitute for, rather than simply add to, diabetes-labeled ...
Clinicians break down HIV PrEP, its near-99% protection, and who’s missing out—women, youth, and Southern communities in PrEP ...
Tozorakimab (MEDI3506) met its primary and key secondary end points in the Phase 3 OBERON ( NCT05166889) and TITANIA ( ...
The FDA approved tavapadon (Juvmo) tablets for the treatment of adults with Parkinson disease (PD). The company described the ...
Lean-mass changes should be interpreted with performance endpoints, including handgrip strength, rather than isolated ...
Documentation limitations were the most frequently identified theme and included the absence of structured menopause-specific ...
Vaccination and natural infection both train the immune system, but only one route carries the added risk of long COVID and ...
Enrolled participants were predominantly vertically infected, long-term suppressed adolescents; dosing transitioned from initial injections to maintenance every 8 weeks, with median follow-up ...
The update adds efficacy and safety data on adults newly diagnosed with pulmonary arterial hypertension. HYPERION enrolled 320 adults with PAH, randomizing 160 to Winrevair and 160 to placebo added to ...
Heading into the 2026 respiratory virus season, pharmacists have historically been tasked with matching the right product with the right symptom for the right patient, rather than letting marketing ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results